Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Debt (2016 - 2025)

Surgery Partners (SGRY) has disclosed Total Debt for 12 consecutive years, with $3.7 billion as the latest value for Q4 2025.

  • Quarterly Total Debt rose 9.85% to $3.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Dec 2025, up 9.85% year-over-year, with the annual reading at $3.7 billion for FY2025, 9.85% up from the prior year.
  • Total Debt hit $3.7 billion in Q4 2025 for Surgery Partners, up from $3.6 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $3.7 billion in Q4 2025 to a low of $2.6 billion in Q2 2023.
  • Historically, Total Debt has averaged $3.1 billion across 5 years, with a median of $3.0 billion in 2021.
  • Biggest five-year swings in Total Debt: dropped 16.78% in 2023 and later grew 23.68% in 2025.
  • Year by year, Total Debt stood at $2.9 billion in 2021, then dropped by 10.79% to $2.6 billion in 2022, then grew by 5.85% to $2.8 billion in 2023, then rose by 21.45% to $3.4 billion in 2024, then rose by 9.85% to $3.7 billion in 2025.
  • Business Quant data shows Total Debt for SGRY at $3.7 billion in Q4 2025, $3.6 billion in Q3 2025, and $3.6 billion in Q2 2025.